Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P910001/S127

Philips Laser System

Spectranetics Corp. · Decision date Aug 21, 2026

FDA DECISIONP910001/S127

What did the FDA decide?

FDA records P910001/S127 as a supplement to PMA P910001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 21, 2026.

FDA approval order statement

the implementation of a secondary supplier for cable assemblies
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Aug 21, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P910001/S127
Regulatory pathway
PMA supplement
Product code
LPC
Decision code
OK30
Decision date
Aug 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEVICE, ANGIOPLASTY, LASER, CORONARY.

Product code
LPC
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P910001/S125 · Related supplement

    ELCA Coronary Atherectomy Catheters

  2. P910001/S124 · Related supplement

    ELCA Coronary Atherectomy Catheters

  3. P910001/S127 received

    Application receipt date recorded by FDA.

  4. P910001/S126 · Related supplement

    ELCA Coronary Laser Atherectomy Catheters

  5. P910001/S127 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P910001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P910001

Product / regulatory recordCompanyPathwayDecision dateSource
Spectranetics Corp.PMA supplementDec 18, 2025FDA
Spectranetics Corp.PMA supplementFeb 6, 2026FDA
Spectranetics Corp.PMA supplementAug 14, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Spectranetics Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9965 Federal Dr., Colorado Springs, CO, 80921

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records